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ohe need for right ventricular outflow tract reconstruction
and pulmonary valve replacement is increasing for many
ongenital heart patients. In the past, residual defects such as
hronic pulmonary insufficiency in postoperative tetralogy of
allot patients were felt to be benign. More recent evidence
uggests that pulmonary insufficiency (PI) and right ventric-
lar volume overload cause significant morbidity, producing
ight ventricular dilation and dysfunction, exercise intoler-
nce, arrhythmias, and possibly sudden death.1,2 Pulmonary
alve replacement (PVR) enables symptomatic improvement
nd improved right heart function and is beneficial in con-
rolling arrhythmias. Indications for PVR are evolving and
nclude moderate or severe PI with exertional symptoms or
oor exercise testing, significant right ventricular dilation
150 mL/m2 by magnetic resonance imaging), right ven-
ricular dysfunction, significant arrhythmias, or prolonged
RS duration (180 ms).3
There are many prosthetic valve options for PVR. There is
o ideal valve, and all choices have significant limitations.
ost patients receive a bioprosthesis such as a homograft or
eterograft, either stented or unstented. All of these valves are
onliving, do not self-repair, and share a common durability
ssue. They undergo a biodegenerative process and ulti-
ately will fail with obstruction and/or insufficiency over
ime. Current interest is high with regards to viable, tissue-
ngineered valves, but many issues need resolution before
hese are in everyday practice. Alternatively, a nonbiologic
ardiac Surgical Associates, St. Petersburg, Florida.
ddress reprint requests to James A. Quintessenza, MD, Cardiac Surgical
Associates, 625 Sixth Avenue South, Suite 475, St. Petersburg, FLR33701. E-mail: jaqmd@hotmail.com
44 1522-2942/08/$-see front matter © 2008 Elsevier Inc. All rights reserved.
doi:10.1053/j.optechstcvs.2008.11.001hoice, such as polytetrafluoroethylene (PTFE), can be con-
idered. There is reasonable experience with monocusp
TFE reconstruction of the right ventricular outflow tract
ith regard to function and leaflet durability.4,5 This article
emonstrates the implant technique for a bicuspid valve de-
ign using 0.1 mm PTFE for the valve leaflets.
The initial report of this technique6 includes the first 41
atients of our series, demonstrating improvement in pulmo-
ary insufficiency, right ventricular end-diastolic dimen-
ions, and symptoms over a mean follow-up period of 18
onths. At present, there are more than 110 patient implants
ith follow-up extending out to 8 years. Three of the early
mplants using a porous 0.6 mm PTFE material have been
xplanted due to immobile and calcified leaflets. We cur-
ently use nonporous 0.1 mm PTFE which does not allow
ellular ingrowth and thickening as reported by others in
onocusp applications.5 Early echocardiographic follow-up
f these valve leaflets demonstrate improved mobility and
liability, and lower transvalvar gradients. It is anticipated
hat utilizing this thinner PTFE will result in improved valve
unction and durability.
PTFE bicuspid PVR has been used in somewhat older chil-
ren (8 years) and young adults, where a 24-mm orifice of
he valve can be obtained. This approach is aimed at avoiding
utgrowth of the valve as a mode of failure. An ideal implant
ecipient is the patient who has undergone previous repair of
etralogy of Fallot with a transannular patch, leading to severe
I and right ventricular dilation. Additionally, patients who
ave undergone a variety of other operations, such as repair
f pulmonary stenosis, double-outlet right ventricle, or the
oss procedure, can be operated with this technique.
PTFE bicuspid pulmonary valve implantation 245Operative Technique
which could result in distortion and/or perivalvar leakage.Figure 1 Implantation is performed using cardiopulmo
clamping with cardioplegic arrest is generally used, as
Patients without septal defects or a need for concomita
beating heart. The right ventricular outflow tract is diss
or just above, the level of the original pulmonary valve a
midportion down into what is usually the old transa
reconstruction or branch pulmonary artery enlargement
infundibular septum is inspected and the transverse d
visualize the proposed triangular-shaped pathway for the
the suture lines can be constructed without interferenc
(VSD) patch, or large right ventricular muscle bundles,nary bypass usually with bicaval cannulation. Aortic cross-
it provides a more optimal surgical field for implantation.
nt procedures can be operated with mild hypothermia and a
ected from surrounding tissues and stay sutures are placed at,
nnulus. The main pulmonary artery (MPA) is opened from its
nnular patch for a distance of 3 to 4 cm. Any supravalvar
can be incorporated by extending this incision cephalad. The
iameter of the proximal MPA is measured. It is important to
posterior and anterior leaflet suture lines, making certain that
e from structures such as a calcified ventricular septal defect
246 J.A. QuintessenzaFigure 2 The bicuspid leaflets are cut from a folded-over sheet of 0.1 mm PTFE in the shape of a bishop’s miter. The
dimension of the leading edge is approximately 1.8 times the diameter of the proximal MPA at the level where the outlet
end of the valve will be sutured into place. The length is approximately 0.9 times the width. The folded edge is incised,
leaving 2 to 3 mm of material intact at either end, to create the orifice of the valve. PTFE  polytetrafluoroethylene.
PTFE bicuspid pulmonary valve implantation 247Figure 3 Implantation is begun by placing two 5-0 Prolene mattress anchoring sutures through the corners of the outlet
end of the folded valve leaflets, securing them at the 3 and 9 o’clock positions in the proximal MPA just above the level
of the pulmonary annulus. Ant.  anterior; Post.  posterior.
248 J.A. QuintessenzaFigure 4 (A) The posterior leaflet is sewn from its apex toward the orifice, onto the infundibular septum, working the
suture line anteriorly to end at the 3 and 9 o’clock positions of the initial anchoring sutures. (B) The anterior leaflet is
sewn from its apex toward the orifice, beginning at the vertex of the infundibulotomy incision, working the suture line
posteriorly and laterally along the sides of the infundibular outlet, down to the level of the initial anchoring sutures at
the 3 and 9 o’clock positions. Optimally, the suture lines and leaflets should parallel each other and be side-by-side for
the upper one-third of their course to maximize coaptation. The orifice and suture lines are inspected for integrity (C).
An oval patch of pericardium or PTFE is used to close the resultant defect, maintaining the original measured diameter,
or 24 mm as a minimum (D).
The right heart is de-aired, and the patient is rewarmed and weaned from cardiopulmonary bypass. Postoperative
transesophageal echocardiography should demonstrate a competent valve with a low transannular gradient. Patients
are maintained on low-dose aspirin postoperatively. Ant.  anterior; Post.  posterior.
R
1
2
3
4
5
6
(Cont
PTFE bicuspid pulmonary valve implantation 249eferences
. Bouzas B, Kilner PJ, Gatzoulis MA: Pulmonary regurgitation: not a be-
nign lesion. Eur Heart J 26:433-439, 2005
. Frigiola A, Redington AN, Cullen S, et al: Pulmonary regurgitation is an
important determinant of right ventricular contractile dysfunction in
patients with surgically repaired tetralogy of Fallot. Circulation 110:153-
157, 2004 (suppl 2)
. Davroulos PA, Karatza AA, Gatzoulis MA, et al: Timing and type of
surgery for severe pulmonary regurgitation late after repair of Tetralogy
Figure 4of Fallot. Int J Cardiol 97:91-101, 2004. Morita K, Kaurosawa H, Nomura K, et al: Right ventricular outflow tract
reconstruction with PTFE mono-cusped transannular patch for Tetral-
ogy of Fallot. Kyobu Geka 54:631-636, 2001 (suppl 8)
. Brown JW, Ruzmetov M, Vijay P, et al: Right ventricular outflow tract
reconstruction with a polytetrafluoroethylenemonocusp valve: a twelve-
year experience. J Thorac Cardiovasc Surg 133:1336-1343, 2007
. Quintessenza JA, Jacobs JT, Morell VO, et al: Initial experience with a
bicuspid PTFE pulmonary valve in 41 children: a new option for right
ventricular outflow tract reconstruction. Ann Thorac Surg 79:924-931,
inued)2005
